(firstQuint)GORE TAG Thoracic Endoprosthesis French Mandatory Registry.

 Endovascular therapy to treat thoracic disease seems to provide a plausible benefit compared to surgery in terms of operative mortality and severe morbidity.

 The French National Health Authority (HAS) requires a 5-year follow-up as part of the renewal of reimbursement for these endoprostheses in order to collect long-term follow-up data under real-life conditions of use.

.

 GORE TAG Thoracic Endoprosthesis French Mandatory Registry@highlight

This is a French Registry mandated by the French National Health Authority assessing long-term (5-years) safety of the GORE(R) TAG(R) Thoracic Endoprosthesis treating diseases of the thoracic aorta.

